Free Trial
NASDAQ:AFIB

Acutus Medical (AFIB) Stock Price, News & Analysis

Acutus Medical logo
$0.0005 0.00 (0.00%)
As of 08/22/2025 09:30 AM Eastern

About Acutus Medical Stock (NASDAQ:AFIB)

Key Stats

Today's Range
$0.0005
$0.0005
50-Day Range
N/A
52-Week Range
$0.00
$0.22
Volume
2,740 shs
Average Volume
41,302 shs
Market Capitalization
$14.89 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

AFIB Stock News Headlines

Analyzing H-CYTE (OTCMKTS:HCYTD) & Acutus Medical (NASDAQ:AFIB)
AFIB Acutus Medical, Inc. - Seeking Alpha
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Acutus Medical Reports Full Year 2024 Financial Results
Acutus Medical Announces Operational Downsizing
Acutus Medical Reports Q3 2024 Financial Results
See More Headlines

AFIB Stock Analysis - Frequently Asked Questions

Acutus Medical's stock was trading at $0.0550 at the beginning of 2025. Since then, AFIB shares have decreased by 99.1% and is now trading at $0.0005.

Acutus Medical, Inc. (NASDAQ:AFIB) announced its quarterly earnings results on Thursday, November, 11th. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of ($0.92) by $0.02. The business earned $4.60 million during the quarter, compared to the consensus estimate of $6.02 million. Acutus Medical had a negative net margin of 272.74% and a negative trailing twelve-month return on equity of 311.64%.

Acutus Medical subsidiaries include these companies: Acutus Medical N.V..

Acutus Medical (AFIB) raised $126 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Enterprise Products Partners (EPD), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), Nextera Energy Partners (NEP), PayPal (PYPL) and Rio Tinto (RIO).

Company Calendar

Last Earnings
11/11/2021
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:AFIB
CIK
1522860
Employees
340
Year Founded
2011

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.66 million
Net Margins
-272.74%
Pretax Margin
-30.32%
Return on Equity
-311.64%
Return on Assets
-11.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.85
Quick Ratio
1.57

Sales & Book Value

Annual Sales
$7.16 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
-0.02

Miscellaneous

Outstanding Shares
29,779,000
Free Float
28,228,000
Market Cap
$14.89 thousand
Optionable
Optionable
Beta
-0.62

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:AFIB) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners